bone marrow biopsy on [**2153-3-1**] consistent with myeloproliferative disorder (polycythemia [**Doctor First Name **])...as well as an abnormal karyotype with deletion 20q in 3 out of 20 metaphases increasing his risk of hypercoagulability.
(8) Gastritis, detected on EGD in [**2153-6-30**].
(10) h/o thrombophlebitis in left leg (11) uveitis (12) C4-C5 radiculopathy (13) HLD (14) HTN (15) recurrent autoimmune pericarditis (16) h/o benign pancreatic cyst s/p resection   Social History: Lives with wife, has grown children.
Family History: Pancreatic Cancer  Physical Exam: In ED at presentation: VS: 97.4 78 165/109 18 100RA pain [**8-2**] Gen: NAD, AOx3 HEENT: MMM, trachea midline, neck supple CV: +S1, +S2 no murmurs/rubs/gallops Pulm: Lungs clear to auscultation bilaterally Abd:  Softly distended, tympanitic.
+bowel sounds Rectal: guaiac neg Extremities: warm, no edema, +DP and radial pulses   Pertinent Results: [**2157-8-21**] CT ABDOMEN W/CONTRAST 1.
[**2157-8-21**] 03:40PM   WBC-4.4 RBC-3.71* HGB-9.8* HCT-31.8* MCV-86 MCH-26.5* MCHC-30.9* RDW-22.7* [**2157-8-21**] 03:40PM   NEUTS-78* BANDS-0 LYMPHS-15* MONOS-5 EOS-1 BASOS-0 ATYPS-1* METAS-0 MYELOS-0 NUC RBCS-3* [**2157-8-21**] 03:40PM   PT-57.8* PTT-37.2* INR(PT)-6.5* [**2157-8-21**] 03:40PM   GLUCOSE-194* UREA N-31* CREAT-1.6* SODIUM-139 POTASSIUM-4.0 CHLORIDE-102 TOTAL CO2-26 ANION GAP-15 [**2157-8-21**] 09:16PM   LACTATE-1.0 [**2157-8-21**] 03:40PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-25 GLUCOSE-100 KETONE-TR BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-TR [**2157-8-21**] 03:40PM URINE  COLOR-Yellow APPEAR-Clear SP [**Last Name (un) 155**]-1.022 [**2157-8-21**] 03:40PM URINE  RBC-0-2 WBC-0-2 BACTERIA-OCC YEAST-NONE EPI-0-2 [**2157-8-21**] 03:40PM URINE  HYALINE-[**2-25**]*  [**8-25**] AXR: dilated loops of small bowel with air in the colon  [**8-25**] Barium Enema: No gross contrast extravasation.
[**8-27**] ECHO: EF 40%, ascending aorta is mildly dilated.
Tiny focus of extraluminal density is noted near anastomosis - leak.
[**8-30**] IR US: Feculent material drained  [**9-2**] Echo: mild LVH, EF>55%, no vegetations seen on valves  [**9-3**] CT torso: marked interval decrease in intra-abdominal fluid collection, left basilar atelectasis, left pleural effusion  [**9-4**] RUE U/S: Prelim- DVT in basillic/ axillary not traveling to IJ  [**9-7**] CT A/P, CTA chest - Segmental PE in the right upper and middle lobe.
[**10-19**] AP chest compared to [**Date range (1) 51011**]: Left lower lobe is still collapsed, accompanied by moderate left pleural effusion.
Brief Hospital Course: [**2157-8-22**]: sigmoid colectomy + diverting ileostomy [**2157-9-6**]: Flexible bronchoscopy with bronchoalveolar lavage and therapeutic aspiration [**2157-9-12**]: ex-lap, removal of mesh from previous hernia repair, abdominal washout [**2157-9-13**]: emergent exlap, hematoma evacuation, abdominal packing, temporary closure [**2157-9-14**]: exlap, removal of packing, closure fascia [**2157-9-15**]: perc trach [**2157-9-19**]: exlap, hematoma evacuation, closure of leak site at anastamosis [**2157-9-22**]: left index finger amputation [**2157-9-26**]: pigtail catheter placement for L pleural effusion [**2157-9-29**]: bronchoscopy, removal of mucous plugging [**2157-9-30**]: bronchoscopy, removal of mucous plugging [**2157-10-17**]: bronchoscopy, removal of mucous plugging  The pt was admitted on [**2157-8-21**] with a large bowel obstruction.
He was taken to the OR on [**2157-8-22**] for an exploratory laparotomy with sigmoid colectomy and diverting ileostomy for diverticular stricture.
His last Echo showed an EF of >55%.
He also had a PE treated with hep gtt, argatroban gtt, and transitioned to warfarin prior to discharge.
Earlier in his hospital course, he required numerous bronchoscopies in order to reinflate his lungs (mostly the left lung) and remove clinically significant mucous plugs.
On one of his takebacks, a small area of leak was noted on the back side of his anastamosis, which was sutured.
His antibiotic treatments are summarized as follows: vancomycin ([**Date range (1) 29441**]), meropenem ([**Date range (1) 51012**] ), fluconazole ([**Date range (1) 51013**]), flagyl ([**8-26**]- [**9-1**], [**Date range (1) 51014**]), Linezolid (9/8-10-11), ceftaz ([**9-16**] - [**9-29**]), cipro ([**Date range (1) 51015**]), cefepime ([**Date range (1) 51016**]), vanc/cipro/zosyn ([**Date range (1) 51017**]).
Disp:*60 Tablet(s)* Refills:*0* 8. polyvinyl alcohol-povidone 1.4-0.6 % Dropperette [**Last Name (STitle) **]: [**12-25**] Drops Ophthalmic PRN (as needed) as needed for dry eyes.
9. sodium polystyrene sulfonate 15 g/60 mL Suspension [**Month/Day (2) **]: Fifteen (15) grams PO Q6H (every 6 hours) as needed for K greater than 5.4.
sliding scale 12. tizanidine 2 mg Tablet [**Month/Day (2) **]: Two (2) Tablet PO TID (3 times a day).
Disp:*10 Patch 72 hr(s)* Refills:*2* 15. warfarin 5 mg Tablet [**Month/Day (2) **]: Two (2) Tablet PO daily, adjust per INR 16. alum-mag hydroxide-simeth 200-200-20 mg/5 mL Suspension [**Month/Day (2) **]: 15-30 MLs PO QID (4 times a day) as needed for discomfort/nausea.
mg 24. ondansetron HCl (PF) 4 mg/2 mL Solution [**Month/Day (2) **]: Four (4) mg Injection Q8H (every 8 hours) as needed for nausea.
Followup Instructions: Provider: [**First Name8 (NamePattern2) **] [**Name11 (NameIs) **], MD,PHD[**MD Number(3) 708**]:[**Telephone/Fax (1) 22**] Date/Time:[**2157-10-27**] 11:00 Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 647**], MD Phone:[**Telephone/Fax (1) 22**] Date/Time:[**2157-11-3**] 2:30  Provider: [**Name10 (NameIs) **] SCAN Phone:[**Telephone/Fax (1) 327**] Date/Time:[**2158-2-2**] 11:00  Please call Dr.[**Name (NI) 6218**] office at ([**Telephone/Fax (1) 15665**] in order to schedule a follow up appointment in 2 weeks.
